ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1667

Correlates of Physical Activity (PA) in Persons Undergoing Total Knee Arthroplasty (TKA): Does Pain Matter?

Elena Losina1, Jamie Collins1, Clare Safran-Norton1, Mike Paskewicz1, Faith Selzer2, Sonia Pavlesen3, Kelly Frier1, Jon Dhani1, Darya Lee1, Ella Macdonald3, Alexa Streicher3, Linda Ehrlich-Jones4, Neil Segal5, Christine Pellegrini6, Elizabeth Wellsandt7, Rowland Chang8 and Jeffrey Katz1, and KArAT Team, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Amesbury, MA, 3University of Buffalo, Buffalo, NY, 4Shirley Ryan Ability Lab, Chicago, IL, 5University of Kansas, Kansas City, KS, 6University of South Carolina, Columbia, SC, 7University of Nebraska Medical Center, Omaha, NE, 8Northwestern University Division of Rheumatology, Chicago, IL

Meeting: ACR Convergence 2024

Keywords: Arthroplasty, body mass, Osteoarthritis, pain, physical activity

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Low PA in persons with symptomatic knee osteoarthritis (OA) has often been attributed to pain. Evolving data suggest that TKA recipients do not increase PA after TKA despite satisfaction with pain relief in 72-86% of recipients. We sought to determine demographic, clinical, psychological, and physical performance characteristics that correlate with PA in TKA recipients.

Methods: We analyzed data from persons with OA scheduled for TKA undergoing eligibility assessment for the 4-center Knee Arthroplasty Activity Trial (KArAT). KArAT is designed to establish the efficacy of a behavioral intervention to increase walking-based PA post TKA. The baseline assessment includes body mass index (BMI), knee injury and osteoarthritis outcome score (KOOS) pain, Tampa Kinesiophobia Score ( >37 indicates fear of movement), quadriceps strength, and 40-meter timed walk. We defined very low muscle strength as two standard deviations (SD) below age/sex-stratified population norms. We defined low walking speed as < 20th percentile of age/sex-stratified population norms. We assessed the average daily step count and weekly moderate to vigorous physical activity (MVPA) using Actigraph. To reduce the impact of outliers, we restricted the sample to include those within 95% of step count distribution. We used generalized linear models to determine independent correlates of average daily step count and weekly MVPA considering demographic, clinical, psychological, and physical performance characteristics.

Results: The sample of 330 individuals had a mean age 65.8 (SD 8.0) years, KOOS pain 49.2 (SD 16.2), and BMI 31.3 (SD 6.1) kg/m2. On average, study participants walked 4,095 steps/day (SD 2163). The median time in MVPA was 54 min/week (IQR 24—117), 25% of the sample met criteria as slow walkers, and 35% had kinesiophobia. One third (31%) of the sample had quadricep strength < -2 SD of population norms. Independent correlates of step count included age, sex, BMI, slow walking speed, very low quadricep strength, and kinesiophobia (Figure). Pearson correlation between average daily step count (weekly MVPA) and KOOS pain was r=-0.03 (-0.04). Age and sex exhibited the strongest association with average step count: those >75 years walked a mean of 2501 steps/day compared to 4372 steps/day in those < 65; men walked about 700 steps (1/3 SD) more than women. Those with BMI >30 kg/m2 walked >1SD fewer steps compared to those with BMI< 25kg/m2 (2345 vs. 4950 steps/day). Slow walkers averaged 3263 steps/day; those with kinesiophobia 3224. Persons with very low quadricep strength averaged 2983 steps/day. Factors associated with lower MVPA time included older age, higher BMI, female sex, very low quadriceps strength, and slow walking speed.

Conclusion: In persons scheduled for TKA, age, BMI, quadricep strength, and walking speed correlated with objectively measured PA, while pain did not. Our findings reinforce the idea that pain relief afforded by TKA alone is unlikely to lead to improved PA. Motivational interventions focused on improving strength, reducing kinesiophobia and excess weight, and reinforcing the benefits of PA may contribute to improvements in PA uptake post TKA.

Supporting image 1

Mean Step Count by BMI, Age, Sex, Quadriceps Strength, Fear of Movement, and Slow Walking Speed


Disclosures: E. Losina: None; J. Collins: Boston Imaging Core Lab LLC, 2; C. Safran-Norton: None; M. Paskewicz: None; F. Selzer: None; S. Pavlesen: None; K. Frier: None; J. Dhani: None; D. Lee: None; E. Macdonald: None; A. Streicher: None; L. Ehrlich-Jones: None; N. Segal: Arthrex, 1, Pacira Biosciences, 2, 5, 6, Trice Medical, 6; C. Pellegrini: None; E. Wellsandt: None; R. Chang: None; J. Katz: None.

To cite this abstract in AMA style:

Losina E, Collins J, Safran-Norton C, Paskewicz M, Selzer F, Pavlesen S, Frier K, Dhani J, Lee D, Macdonald E, Streicher A, Ehrlich-Jones L, Segal N, Pellegrini C, Wellsandt E, Chang R, Katz J. Correlates of Physical Activity (PA) in Persons Undergoing Total Knee Arthroplasty (TKA): Does Pain Matter? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/correlates-of-physical-activity-pa-in-persons-undergoing-total-knee-arthroplasty-tka-does-pain-matter/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlates-of-physical-activity-pa-in-persons-undergoing-total-knee-arthroplasty-tka-does-pain-matter/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology